Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

Timing Is Everything in Preventing HIV Spread From Mom to Baby

WebMD Health News
Reviewed by Annie Finnegan

Oct. 4, 2000 -- HIV-infected pregnant women pass the virus on to their unborn babies less often if they begin treatment earlier in the course of pregnancy rather than later, researchers have found.

"The message is, 'Get tested early,'" says Kenneth McIntosh, MD, professor of pediatrics at Harvard Medical School and a co-author of the study. "There's a utility in taking AZT [a drug used to treat HIV] for a longer period of time." The study appears in the Oct. 5 issue of the New England Journal of Medicine.

The researchers also tried to determine the length of time that newborns should be given AZT to further prevent them from getting the virus. They found that babies born to HIV-infected mothers -- in cases where the mothers had taken a full course of AZT treatment -- were no more likely to develop HIV if they had taken AZT for three days than if they had taken them for six weeks.

That is an interesting finding and may change the way some physicians treat their newborn patients, says Edward Handelsman, MD, a lead researcher in pediatric HIV studies at the State University of New York Health Science Center in Brooklyn. "I would be much more comfortable giving the shorter dose to infants, or at least offering parents the option," especially if the baby isn't tolerating AZT very well, he tells WebMD.

In the study, Marc Lallemant, MD, of the Institute of Research and Development in Paris, and colleagues studied almost 1,500 pregnant women in Thailand, average age 25, who were infected with HIV. The researchers wanted to find out what the optimal length of AZT treatment was for both mothers and newborns to prevent transmission of HIV to the baby.

They divided the women into four groups -- all starting AZT at different points in their pregnancy with varying lengths of AZT treatment in their newborns as well.

The researchers found considerable differences among the three groups. The women who started AZT at the 28th week of pregnancy with their newborns taking the drug for three days did the best. Only 5% of these babies became infected with HIV.

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore